Keck School Faculty

Gary Robert Lerner, MD
Gary Robert Lerner, MD
Associate Professor of Clinical Pediatrics
CHL Mail Stop 40 Off Campus Los Angeles

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease Pediatr Nephrol. 2017 Jul; 32(7):1221-1232. . View in PubMed

Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease Pediatr Nephrol. 2006 Aug; 21(8):1144-52. . View in PubMed

Experience with autogenous arteriovenous access for hemodialysis in children and adolescents Ann Vasc Surg. 2005 Sep; 19(5):609-12. . View in PubMed

Iron therapy in the pediatric hemodialysis population Pediatr Nephrol. 2004 Jun; 19(6):655-61. . View in PubMed

Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis Pediatr Transplant. 2004 Apr; 8(2):151-60. . View in PubMed

Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease Pediatr Nephrol. 2002 Nov; 17(11):933-7. . View in PubMed

Chronic dialysis in children and adolescentsThe 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1999 Jun; 13(5):404-17. . View in PubMed

Urinary tract infections in children Pediatr Ann. 1994 Sep; 23(9):463, 466-73. . View in PubMed

Renal cortical and renal medullary necrosis in the first 3 months of life Pediatr Nephrol. 1992 Nov; 6(6):516-8. . View in PubMed

Powered by SC CTSI
Go to Top